• CORRECTION: A version of this story published online on June 18 stated Jingwu Z. Zhang was asked not to contact certain people because of a disputed paper. Zhang says the paper was not mentioned, and this story has been revised to reflect that.

Volume 91 Issue 25 | p. 7 | News of The Week
Issue Date: June 24, 2013 | Web Date: June 20, 2013

Fired Researcher Denies Blame For Disputed Data

Research Integrity: Former GSK R&D leader in China claims mix-up in paper was inadvertent
Department: Business
Keywords: China, multiple sclerosis, pharmaceutical R&D, ethics

A former GlaxoSmithKline executive, Jingwu Z. Zhang, who was in charge of the company’s neuroscience R&D effort worldwide as well as its China research operations, says he is being unfairly blamed for allegedly misrepresenting data in a research paper published in Nature Medicine in 2010 (DOI: 10.1038/nm.2077).

The paper concerns a hypothesized genetic link for multiple sclerosis. Earlier this . . .

To view the rest of this content, please log in with your ACS ID.

Chemical & Engineering News
ISSN 0009-2347
Copyright © American Chemical Society